Written by Harold Oster, MD. Results suggest that a topical solution containing frankincense may improve pain and function in patients with knee osteoarthritis.

joint healthOsteoarthritis affects more than two hundred million people worldwide. It causes the destruction of cartilage and bone, leading to pain, stiffness, and loss of function1. Frankincense, the resin of trees from the Boswellia genus, has been used in traditional medicine for thousands of years. Recently, frankincense has been shown to have anti-inflammatory and antioxidant properties2 and may have benefits in the treatment of arthritis3.

Afsaneh Mohsenzadeh et al. studied the effectiveness of an oil-based topical solution containing frankincense from Borrelia serrata in the treatment of patients with knee osteoarthritis. Patients between forty and eighty years old with mild to moderate arthritis as assessed on the Kellgren and Lawrence radiologic grading scale4 were recruited from a rheumatology clinic in Dubai. They were randomized to apply a solution of one gram of frankincense in black seed and olive oil or a placebo to the involved knee three times a day for four weeks. Patients in both groups were prescribed oral acetaminophen 500 mg three times daily. At baseline and at the end of the study, patients were assessed for pain with the Visual Analog Scale5, for stiffness, pain, and physical function with the Western Ontario and McMaster Universities Arthritis Index (WOMAC)6, and overall symptoms with the Patient Global Assessment (PGA)7.

The authors noted the following:

  • Based on exclusion criteria, seventy patients completed the study.
  • At the end of the study, participants in the frankincense group and the placebo group improved on the Visual Analog Scale, all three aspects of WOMAC, and the Patient Global Assessment.
  • The participants in the frankincense group improved to a greater degree in all testing than those in the placebo group.

Results suggest that topical application of an oil-based solution containing frankincense is beneficial in the treatment of knee osteoarthritis. Limitations of the study include a small sample size and the inability to ascertain how much of the study drug was used by the participants.

Source: Mohsenzadeh, Afsaneh, Mansoor Karimifar, Rasool Soltani, and Valiollah Hajhashemi. “Evaluation of the effectiveness of topical oily solution containing frankincense extract in the treatment of knee osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial.” BMC Research Notes 16, no. 1 (2023): 28.

© The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativeco mmons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Click here to read the full text study.

Posted December 13, 2023.

Harold Oster, MD graduated from medical school in Miami, Florida in 1992 and moved to Minnesota in 2004. After more than 25 years of practicing Internal Medicine, he recently retired. Dr. Oster is especially interested in nutrition, weight management, and disease prevention. Visit his website at haroldoster.com.

References:

  1. Katz JN, Arant KR, Loeser RF. Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review. Jama. Feb 9 2021;325(6):568-578. doi:10.1001/jama.2020.22171
  2. Al-Yasiry AR, Kiczorowska B. Frankincense–therapeutic properties. Postepy Hig Med Dosw (Online). Jan 4 2016;70:380-91. doi:10.5604/17322693.1200553
  3. Almeida-da-Silva CLC, Sivakumar N, Asadi H, et al. Effects of Frankincense Compounds on Infection, Inflammation, and Oral Health. Molecules. Jun 29 2022;27(13)doi:10.3390/molecules27134174
  4. Kohn MD, Sassoon AA, Fernando ND. Classifications in Brief: Kellgren-Lawrence Classification of Osteoarthritis. Clin Orthop Relat Res. Aug 2016;474(8):1886-93. doi:10.1007/s11999-016-4732-4
  5. Stauffer ME, Taylor SD, Watson DJ, Peloso PM, Morrison A. Definition of nonresponse to analgesic treatment of arthritic pain: an analytical literature review of the smallest detectable difference, the minimal detectable change, and the minimal clinically important difference on the pain visual analog scale. Int J Inflam. 2011;2011:231926. doi:10.4061/2011/231926
  6. Woolacott NF, Corbett MS, Rice SJ. The use and reporting of WOMAC in the assessment of the benefit of physical therapies for the pain of osteoarthritis of the knee: findings from a systematic review of clinical trials. Rheumatology (Oxford, England). Aug 2012;51(8):1440-6. doi:10.1093/rheumatology/kes043
  7. Gentelle-Bonnassies S, Le Claire P, Mezieres M, Ayral X, Dougados M. Comparison of the responsiveness of symptomatic outcome measures in knee osteoarthritis. Arthritis Care Res. Oct 2000;13(5):280-5. doi:10.1002/1529-0131(200010)13:5<280::aid-anr6>3.0.co;2-6